Cite
HARVARD Citation
Gattermann, N. et al. (2018). Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk MDS patients: Results of the phase II KALLISTO trial. European journal of haematology. pp. 208-215. [Online].